BSGM - Biosig Technologies Debt to Book Capitalization Ratio

Corporate company logo of BioSig Technologies, Inc. (BSGM)

The debt-to-market cap dynamics correlate with the dependence of equipment procurement on clinic capital budgets, with the indicator currently standing at 0.00. The business stability of Biosig Technologies (BSGM) is underpinned by the rare expertise of its signal processing engineers. The financial profile of Biosig Technologies (BSGM) is shielded by the diplomatic neutrality of the biomedical sector, which minimizes geopolitical risks and guarantees asset resilience.

BioSig Technologies Inc. - BSGM Debts to Book Capitalization (period 07/04/2022 - 09/12/2025)
Flagship merchandise of BioSig Technologies

To build a high-quality portfolio, I evaluate the stability of the issuer's capital structure. This metric compares total liabilities to the book value of equity to measure the level of debt load. For Biosig Technologies (BSGM), this balance is critical when scaling sales of PUREEP systems for cardiology. Analyzing the total debt-to-book equity ratio allows for an assessment of the business's financial autonomy. This chart's dynamics determine the degree of risk when investing in the company's technological growth.

Competitors of Biosig Technologies

DXCM: Debts to Book Capitalization|penumbrainc.com - Debts to Book Value|Debt to Book Capitalization Ratio Novanta (NOVT)|HAE - Debt to Net Assets Ratio|INSP: Debts to Book Capitalization|PRCT (Procept) - Debts to Book Capitalization|Debt to Book Capitalization Ratio CONMED Corporation CNMD|Debts to Book Capitalization Ratio pulsebiosciences.com|InMode - Debts to Book Capitalization|Debts to Book Value Picard Medical Corp PMI|Debt to Book Value SRDX (Surmodics Corp)|SENS - Debts to Book Capitalization|Debt to Book Value NeuroPace, Inc. NPCE|TCMD - Debt to Book Capital|SANUWAVE - Debts to Book Capitalization|Outset Medical Inc (OM) - Debts to Net Assets|Debts to Book Capitalization ELMD|Debt to Book Value LENSAR Inc (LNSR)|AVITA Medical, Inc. (RCEL) - Debt to Book Value|Debt to Net Assets Ratio PROF (profoundmedical.com)|Baird Medical - Debt to Book Capitalization Ratio|Debt to Book Value EDAP TMS SA EDAP|APYX (Bovie Medical) - Debts to Book Capitalization|ICCM - Debts to Book Value|Debts to Book Capitalization pulmonx.com|TELA Bio (TELA) - Debt to Book Value Ratio|CTSO: Debts to Book Capitalization|Debts to Net Assets Sensus Healthcare Inc|Debts to Book Capitalization ZYXI (Zynex Inc)|Debt to Book Value electrocore.com (ECOR)|Debts to Book Capitalization RBOT (Vicarious Surgical)|Inspira Technologies Oxy B.H.N. Ltd. - Debts to Book Capitalization|ICU - Debt to Book Capitalization Ratio|IRIDEX Corporation (IRIX) - Debt to Book Capitalization Ratio|Debt to Book Value ibs.inc INBS|Beyond Air (XAIR) - Debt to Net Assets Ratio|Debts to Book Capitalization PFSA (Profusa Inc)|Debts to Book Value SSKN|GCTK: Debt to Book Capitalization Ratio|Debt to Net Assets NanoVibronix Inc. NAOV|Debt to Book Value VERO (Venus Concept Corp)|Debts to Book Capitalization Nuwellis Corp NUWE|Debts to Book Capitalization AEMD (Aethlon Medical)|ASXC: Debts to Net Assets|Debt to Book Capitalization Ratio Avinger (AVGR)|CUTR (Cutera Inc.) - Debts to Book Capitalization Ratio|Debt to Book Capitalization Ratio KNW|Debt to Book Value Inari Medical Corp|Nevro Corp. - Debts to Book Capitalization|Debts to Book Value RSLS (reshapelifesciences.com)|SILK - Debt to Book Capitalization Ratio